US Patent 7846908 RNAi modulation of TGF-beta and therapeutic uses thereof
Patent 7846908 was granted and assigned to Alnylam Pharmaceuticals on December, 2010 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7846908 RNAi modulation of TGF-beta and therapeutic uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.